{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:41:34Z","timestamp":1792626094243,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Princess Margaret Cancer Foundation Surgical Oncology Innovations in Equity, Diversity, and Inclusion Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hered Cancer Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Germline\n                      <jats:italic>BRCA1\/2<\/jats:italic>\n                      pathogenic variants account for up to 11% of breast cancer (BC) cases in Nigeria, approximately twice the prevalence reported in high-income populations. However, access to hereditary cancer services remains limited and patient awareness is largely uncharacterized. Prior studies have assessed knowledge of genetic testing among healthy populations or following structured genetic counselling, but none have evaluated baseline awareness at the point of clinical diagnosis. This multicentre study measured baseline awareness of hereditary BC and willingness to undergo\n                      <jats:italic>BRCA1\/2<\/jats:italic>\n                      testing among patients newly diagnosed with BC at three tertiary hospitals, as a pre-implementation evaluation for hereditary cancer services in this setting.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a cross-sectional, multicentre study of 230 newly diagnosed patients with histologically confirmed invasive BC recruited between March 2022 and October 2023 at three tertiary teaching hospitals in Nigeria (Osun, Kwara, and Ebonyi States, representing the South West, North Central, and South East geopolitical zones). A structured, interviewer-administered questionnaire was used to assess knowledge of BC risk factors and symptoms, recognition of hereditary BC, awareness of\n                      <jats:italic>BRCA1\/2<\/jats:italic>\n                      , and willingness to undergo germline testing and engage in family disclosure. Factors associated with knowledge and willingness were examined via univariable and multivariable regression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The median age was 47 years; 66.5% were of low socioeconomic status, and 33.0% had a tertiary education. Most patients presented with advanced disease (stage III\/IV: 73.0%), and among those with available data, 76.3% had triple-negative BC. Recognition that BC can be hereditary was limited (55.6%, 95% CI 49.1\u201361.9%), and prior awareness of\n                      <jats:italic>BRCA1\/2<\/jats:italic>\n                      was extremely low (4.8%; 95% CI 2.7\u20138.4%). According to the multivariable analysis, recognition of hereditary BC was independently associated with education (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and hospital centre (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.024). Despite limited genetic literacy, willingness to undergo\n                      <jats:italic>BRCA1\/2<\/jats:italic>\n                      genetic testing was high (95.7%), with most participants willing to inform siblings (94.8%) and encourage genetic testing for family members (96.1%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Among newly diagnosed patients with BC across three Nigerian tertiary centres, awareness of hereditary BC and\n                      <jats:italic>BRCA1\/2<\/jats:italic>\n                      was low, yet willingness to undergo genetic testing was near-universal. Together with previously reported provider readiness, these findings point to service availability rather than patient or provider attitudes as the principal barrier to introducing hereditary BC services in Nigeria. As these services are being developed in Nigeria and comparable settings across sub-Saharan Africa, the corresponding priority will be to design consent pathways, patient-facing education materials, and provider training that addresses the gap between patient willingness and genetic literacy.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13053-026-00349-8","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T04:45:33Z","timestamp":1785127533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Awareness of hereditary breast cancer and readiness for genetic testing among newly diagnosed patients with breast cancer in Nigeria: a multicentre study"],"prefix":"10.1186","volume":"24","author":[{"given":"Funmilola O.","family":"Wuraola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenine","family":"Ramruthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria L.","family":"Mango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nneka","family":"Sunday-Nweke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olayide","family":"Agodirin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adewale A.","family":"Aderounmu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Ogunyemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boladuro","family":"Olawale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saheed","family":"Lawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna T.","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olalekan","family":"Olasehinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adewale O.","family":"Adisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Reel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olusegun I.","family":"Alatise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulin D.","family":"Cil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"5","key":"349_CR1","doi-asserted-by":"publisher","first-page":"e271","DOI":"10.1016\/j.canep.2012.04.007","volume":"36","author":"E Jedy-Agba","year":"2012","unstructured":"Jedy-Agba E, Curado MP, Ogunbiyi O, et al. Cancer Incidence in Nigeria: A Report from Population-based Cancer Registries. Cancer Epidemiol. 2012;36(5):e271\u20138. https:\/\/doi.org\/10.1016\/j.canep.2012.04.007.","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"349_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"issue":"9801","key":"349_CR3","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/S0140-6736(11)61351-2","volume":"378","author":"MH Forouzanfar","year":"2011","unstructured":"Forouzanfar MH, Foreman KJ, Delossantos AM, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011;378(9801):1461\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(11)61351-2.","journal-title":"Lancet"},{"issue":"12","key":"349_CR4","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1002\/ijc.33484","volume":"148","author":"O Olasehinde","year":"2021","unstructured":"Olasehinde O, Alatise O, Omisore A, et al. Contemporary management of breast cancer in Nigeria: Insights from an institutional database. Int J Cancer. 2021;148(12):2906\u201314.","journal-title":"Int J Cancer"},{"key":"349_CR5","doi-asserted-by":"publisher","unstructured":"Bilani N, Zabor EC, Elson L, Elimimian EB, Nahleh Z. Breast cancer in the United States: a cross-sectional overview. Kane E, ed. J Cancer Epidemiol. 2020;2020:1\u20138. https:\/\/doi.org\/10.1155\/2020\/6387378","DOI":"10.1155\/2020\/6387378"},{"issue":"5","key":"349_CR6","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/bjc.2013.6","volume":"108","author":"S Walters","year":"2013","unstructured":"Walters S, Maringe C, Butler J, et al. Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000\u20132007: a population-based study. Br J Cancer. 2013;108(5):1195\u2013208.","journal-title":"Br J Cancer"},{"issue":"23","key":"349_CR7","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317(23):2402\u201316.","journal-title":"JAMA"},{"key":"349_CR8","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic. Version 3.2026"},{"key":"349_CR9","unstructured":"Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices | npj Genomic Medicine. Accessed July 28. 2021. https:\/\/www.nature.com\/articles\/s41525-018-0046-7"},{"key":"349_CR10","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.2147\/CMAR.S189627","volume":"11","author":"C Forbes","year":"2019","unstructured":"Forbes C, Fayter D, de Kock S, Quek RG. A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of BRCA-mutated breast cancer. Cancer Manag Res. 2019;11:2321\u201337. https:\/\/doi.org\/10.2147\/CMAR.S189627.","journal-title":"Cancer Manag Res"},{"issue":"4","key":"349_CR11","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10689-017-0038-2","volume":"17","author":"GE Felix","year":"2018","unstructured":"Felix GE, Zheng Y, Olopade OI. Mutations in context: implications of BRCA testing in diverse populations. Fam Cancer. 2018;17(4):471\u201383.","journal-title":"Fam Cancer"},{"issue":"28","key":"349_CR12","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1200\/JCO.2018.78.3977","volume":"36","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Walsh T, Gulsuner S, et al. Inherited breast cancer in Nigerian women. J Clin Oncol. 2018;36(28):2820.","journal-title":"J Clin Oncol"},{"issue":"1","key":"349_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13053-025-00315-w","volume":"23","author":"FO Wuraola","year":"2025","unstructured":"Wuraola FO, Dare A, Ramruthan J, et al. Knowledge and perceptions of genetic testing for patients with breast cancer in Nigeria: a survey of healthcare providers. Hereditary Cancer Clin Pract. 2025;23(1):16. https:\/\/doi.org\/10.1186\/s13053-025-00315-w.","journal-title":"Hereditary Cancer Clin Pract"},{"key":"349_CR14","unstructured":"Cil TD, Wuraola FO, Ramruthan J, Reel E. ActioN: Addressing global inequities in breast cancer genetic testing, counselling, and management among patients with breast cancer in Nigeria. ActioN. https:\/\/www.actionstudy.ca\/"},{"issue":"4","key":"349_CR15","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s10897-017-0194-4","volume":"27","author":"SO Ngene","year":"2018","unstructured":"Ngene SO, Adedokun B, Adejumo P, Olopade O. Breast Cancer Genetics Knowledge and Testing Intentions among Nigerian Professional Women. J Genet Counsel. 2018;27(4):863\u201373. https:\/\/doi.org\/10.1007\/s10897-017-0194-4.","journal-title":"J Genet Counsel"},{"key":"349_CR16","doi-asserted-by":"publisher","unstructured":"Adejumo PO, Aniagwu TIG, Awolude OA, et al. Cancer genetic services in a low- to middle-income country: cross-sectional survey assessing willingness to undergo and pay for germline genetic testing. JCO Global Oncol. 2023;9e2100140. https:\/\/doi.org\/10.1200\/GO.21.00140.","DOI":"10.1200\/GO.21.00140"},{"key":"349_CR17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4103\/2008-7802.172803","volume":"6","author":"SO Azubuike","year":"2015","unstructured":"Azubuike SO, Celestina UO. Breast cancer: The perspective of Northern Nigerian women. Int J Prev Med. 2015;6:130.","journal-title":"Int J Prev Med"},{"issue":"3","key":"349_CR18","first-page":"280","volume":"23","author":"LI Abugu","year":"2023","unstructured":"Abugu LI, Nwagu EN, Okeke AI, Odo AN. Knowledge of breast cancer, willingness and barriers to mammography screening among rural women in Enugu State, Nigeria. Afr Health Sci. 2023;23(3):280\u201390.","journal-title":"Afr Health Sci"},{"issue":"4","key":"349_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4314\/ahs.v22i4.4","volume":"22","author":"A Yusuf","year":"2022","unstructured":"Yusuf A, Okafor I, Olubodun T, Onigbogi O. Breast cancer knowledge and screening practices among undergraduates in a Nigerian tertiary institution, Southwest Region. Afr Health Sci. 2022;22(4):16\u201330.","journal-title":"Afr Health Sci"},{"issue":"8","key":"349_CR20","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s10552-018-1047-7","volume":"29","author":"F McKenzie","year":"2018","unstructured":"McKenzie F, Zietsman A, Galukande M, et al. Breast cancer awareness in the sub-Saharan African ABC-DO cohort: African Breast Cancer\u2014Disparities in Outcomes study. Cancer Causes Control. 2018;29(8):721\u201330. https:\/\/doi.org\/10.1007\/s10552-018-1047-7.","journal-title":"Cancer Causes Control"},{"key":"349_CR21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1200\/JGO.19.00260","volume":"6","author":"LC Pruitt","year":"2020","unstructured":"Pruitt LC, Odedina S, Anetor I, et al. Breast cancer knowledge assessment of health workers in Ibadan, Southwest Nigeria. JCO global Oncol. 2020;6:387\u201394.","journal-title":"JCO global Oncol"},{"issue":"1","key":"349_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.21467\/ajss.7.1.81-91","volume":"7","author":"R Edet","year":"2020","unstructured":"Edet R, Ekundina O, Bolarinwa OA, Babajide J, Nwafor JA. Knowledge of breast Cancer and screening methods among rural women in Southwest Nigeria: a mixed method analysis. Adv J Social Sci. 2020;7(1):81\u201391.","journal-title":"Adv J Social Sci"},{"key":"349_CR23","doi-asserted-by":"publisher","first-page":"109536","DOI":"10.1016\/j.pec.2026.109536","volume":"147","author":"A Aranda-Gutierrez","year":"2026","unstructured":"Aranda-Gutierrez A, Villarreal-Garza C, Aguilar-y-Mendez D, et al. Genetic cancer risk knowledge among Mexican pathogenic variant carriers. Patient Educ Couns. 2026;147:109536.","journal-title":"Patient Educ Couns"},{"key":"349_CR24","doi-asserted-by":"publisher","unstructured":"Wuraola FO, Ramruthan J, Reel E, et al. Pilot health care provider education program for BRCA1 \/ 2 genetic testing, counseling, and management in Nigeria. JCO Glob Oncol. 2026;12e2500306. https:\/\/doi.org\/10.1200\/GO-25-00306.","DOI":"10.1200\/GO-25-00306"},{"key":"349_CR25","doi-asserted-by":"crossref","unstructured":"Wuraola FO, Ramruthan J, Reel E, et al. Development and evaluation of a BRCA1\/2 education program for Nigerian healthcare providers. Scientific African. Published online 2026:e03336.","DOI":"10.1016\/j.sciaf.2026.e03336"},{"key":"349_CR26","doi-asserted-by":"crossref","unstructured":"Adejumo PO, Aniagwu TI, Awolude OA, et al. Feasibility of genetic testing for cancer risk assessment programme in Nigeria. ecancermedicalscience. 2021;15.","DOI":"10.3332\/ecancer.2021.1283"},{"issue":"4","key":"349_CR27","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/jgc4.1555","volume":"31","author":"L Ehsan","year":"2022","unstructured":"Ehsan L, Waheed MT, Akbar F, Siddiqui Z, Sattar AK, Kirmani S. Challenges and opportunities in the establishment of a hereditary breast cancer clinic at an academic medical center in a low-middle income country. J Genet Couns. 2022;31(4):998\u20131002. https:\/\/doi.org\/10.1002\/jgc4.1555.","journal-title":"J Genet Couns"},{"key":"349_CR28","first-page":"1588","volume":"17","author":"BSE Mapoko","year":"2023","unstructured":"Mapoko BSE, Ndi KC, Tabola L, et al. Feasibility of cancer genetic counselling and screening in Cameroon: perceived benefits and barriers. ecancermedicalscience. 2023;17:1588.","journal-title":"ecancermedicalscience"},{"key":"349_CR29","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.3332\/ecancer.2024.1744","volume":"18","author":"F Saj","year":"2024","unstructured":"Saj F, Nag S, Nair N, Sirohi B. Management of BRCA-associated breast cancer patients in low and middle-income countries: a review. ecancermedicalscience. 2024;18:1744.","journal-title":"ecancermedicalscience"},{"issue":"5","key":"349_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00268-018-04897-6","volume":"43","author":"CH Yip","year":"2019","unstructured":"Yip CH, Evans DG, Agarwal G, et al. Global Disparities in Breast Cancer Genetics Testing, Counselling and Management. World J Surg. 2019;43(5):5. https:\/\/doi.org\/10.1007\/s00268-018-04897-6.","journal-title":"World J Surg"},{"issue":"1","key":"349_CR31","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s44337-025-00483-7","volume":"2","author":"HC Atanda","year":"2025","unstructured":"Atanda HC, Bello RO, Babatunde MI, Olowosoke CB. Operational status of medical biotechnology in Nigeria and its significance for national health security. Discov Med. 2025;2(1):278. https:\/\/doi.org\/10.1007\/s44337-025-00483-7.","journal-title":"Discov Med"},{"issue":"1","key":"349_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41523-024-00686-8","volume":"10","author":"P Dubsky","year":"2024","unstructured":"Dubsky P, Jackisch C, Im SA, et al. BRCA genetic testing and counseling in breast cancer: how do we meet our patients\u2019 needs? NPJ Breast Cancer. 2024;10(1):77.","journal-title":"NPJ Breast Cancer"},{"issue":"3","key":"349_CR33","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.senol.2022.02.003","volume":"35","author":"DT Esan","year":"2022","unstructured":"Esan DT, Adedeji OA, Ihunanyachi MO, Ramos C. Knowledge, attitude and acceptance of bilateral prophylactic mastectomy among female staff in a private university in Nigeria. Revista de Senolog\u00eda y Patolog\u00eda Mamaria. 2022;35(3):184\u201391.","journal-title":"Revista de Senolog\u00eda y Patolog\u00eda Mamaria"},{"issue":"4","key":"349_CR34","doi-asserted-by":"publisher","first-page":"e2500636","DOI":"10.1200\/GO-25-00636","volume":"12","author":"FO Wuraola","year":"2026","unstructured":"Wuraola FO, Oladele AO, Witty CE, et al. Barriers to Breast Reconstruction After Mastectomy for Breast Cancer Management in Nigeria: Perspectives of Health Care Professionals. JCO Glob Oncol. 2026;12(4):e2500636. https:\/\/doi.org\/10.1200\/GO-25-00636.","journal-title":"JCO Glob Oncol"},{"issue":"1","key":"349_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12910-017-0207-8","volume":"18","author":"GN Samuel","year":"2017","unstructured":"Samuel GN, Dheensa S, Farsides B, Fenwick A, Lucassen A. Healthcare professionals\u2019 and patients\u2019 perspectives on consent to clinical genetic testing: moving towards a more relational approach. BMC Med Ethics. 2017;18(1):47. https:\/\/doi.org\/10.1186\/s12910-017-0207-8.","journal-title":"BMC Med Ethics"},{"issue":"1\u20132","key":"349_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1089\/gtmb.2010.0102","volume":"15","author":"ST Vadaparampil","year":"2011","unstructured":"Vadaparampil ST, Quinn GP, Gjyshi A, Pal T. Development of a Brochure for Increasing Awareness of Inherited Breast Cancer in Black Women. Genetic Test Mol Biomarkers. 2011;15(1\u20132):59\u201367. https:\/\/doi.org\/10.1089\/gtmb.2010.0102.","journal-title":"Genetic Test Mol Biomarkers"},{"issue":"9","key":"349_CR37","doi-asserted-by":"publisher","first-page":"5911","DOI":"10.1245\/s10434-024-15527-y","volume":"31","author":"A Mishra","year":"2024","unstructured":"Mishra A, Deo SVS, Kumar N, et al. A Prospective Questionnaire-Based Study Evaluating Genetic Literacy and Impact of Brief Educational Intervention Among Breast Cancer Patients in a Low- to Middle-Income Country. Ann Surg Oncol. 2024;31(9):5911\u20138. https:\/\/doi.org\/10.1245\/s10434-024-15527-y.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"349_CR38","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.pec.2019.04.014","volume":"102","author":"M Underhill-Blazey","year":"2019","unstructured":"Underhill-Blazey M, Stopfer J, Chittenden A, et al. Development and testing of the KnowGene scale to assess general cancer genetic knowledge related to multigene panel testing. Patient Educ Couns. 2019;102(8):1558\u201364.","journal-title":"Patient Educ Couns"},{"issue":"2","key":"349_CR39","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.pec.2004.02.007","volume":"56","author":"J Erblich","year":"2005","unstructured":"Erblich J, Brown K, Kim Y, Valdimarsdottir HB, Livingston BE, Bovbjerg DH. Development and validation of a breast cancer genetic counseling knowledge questionnaire. Patient Educ Couns. 2005;56(2):182\u201391.","journal-title":"Patient Educ Couns"}],"container-title":["Hereditary Cancer in Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13053-026-00349-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13053-026-00349-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13053-026-00349-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:19:05Z","timestamp":1792624745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13053-026-00349-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["349"],"URL":"https:\/\/doi.org\/10.1186\/s13053-026-00349-8","relation":{},"ISSN":["1897-4287"],"issn-type":[{"value":"1897-4287","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. Ethical approval was obtained from the institutional review boards of all participating centres (#OAUTHC ERC\/2022\/03\/03, #UITH ERC PIN\/2022\/03\/1086 and #AEFUTHA REC\/VOL.3\/2022\/048). Written informed consent was obtained from all individual participants prior to enrollment. Consent procedures were available in English and in the participants\u2019 preferred local language (Yoruba, Igbo, or Hausa).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22"}}